RHT.H — Reliq Health Technologies Income Statement
0.000.00%
Last trade - 00:00TechnologyAdventurousMicro Cap
Annual income statement for Reliq Health Technologies, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2018 June 30th | C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.27 | 0.182 | 1.14 | 1.46 | 8.55 |
| Cost of Revenue | |||||
| Gross Profit | 1.15 | 0.008 | 0.174 | 0.858 | 5.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 14.9 | 13.1 | 12.3 | 13.1 | 16.9 |
| Operating Profit | -12.6 | -12.9 | -11.2 | -11.7 | -8.33 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.8 | -13 | -11.1 | -11.8 | -8.17 |
| Net Income After Taxes | -13.8 | -13 | -11.1 | -11.8 | -8.17 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.8 | -13 | -11.1 | -11.8 | -8.17 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.8 | -13 | -11.1 | -11.8 | -8.17 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.145 | -0.113 | -0.083 | -0.075 | -0.045 |